Sanesco Sanesco Health International is a biomedical company providing healthcare practitioners with clinical tools and products used for neuroendocrine health. | ![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | ![]() ImmusanT ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases. | ![]() Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. | |
Founding Date | Founding Date 2004 | Founding Date 2004 | Founding Date 2010 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Arden, US HQ | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Cambridge, US HQ | Locations Seattle, US HQ |
Employees | Employees 23 | Employees 73 | Employees 2 | Employees 27 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $6.1m (FY, 2022) |
Net income | Net income N/A | Net income ($102.1m) (FY, 2025) | Net income N/A | Net income ($187.9m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 56.2m | Total funding raised $ 72.8m | Total funding raised $ 171m |

Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company
ImmusanT is a clinical development-stage biotechnology company focused on an innovative disease-modifying approach to induce immune tolerance in autoimmune diseases.
View company
Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View company